A Chryseobacterium miningosepticum outbreak in a neonatal ward

Infection Control and Hospital Epidemiology

Volumn 24, Issue 8, 2003, Pages 613-617

  Güngör, Serdal ^a   Özen, Metehan ^a,b   Akinci, Aysehan ^a   Durmaz, Riza ^a  

^a INONU UNIVERSITY   (Turkey)

^b Uran Kent   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINO ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LIPID; MEROPENEM; MINOCYCLINE; PARENTERAL SOLUTION; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN; TIMENTIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; CHRYSEOBACTERIUM; CHRYSEOBACTERIUM MENINGOSEPTICUM; CLINICAL FEATURE; ENDOTRACHEAL TUBE; EPIDEMIC; FEEDING APPARATUS; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PARENTERAL NUTRITION; TONIC CLONIC SEIZURE; ANTIBIOTIC RESISTANCE; CROSS INFECTION; ENVIRONMENTAL MONITORING; FLAVOBACTERIACEAE INFECTION; HEALTH SURVEY; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; TURKEY (REPUBLIC);

CHRYSEOBACTERIUM; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ENVIRONMENTAL MONITORING; FLAVOBACTERIACEAE INFECTIONS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; SENTINEL SURVEILLANCE; TURKEY;

EID: 0042431623     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502261     Document Type: Article

References (21)

1. Steinberg JP, Del Rio C. Other gram-negative bacilli. In: Mandel GL, Bennet JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. Edinburgh: Churchill Livingstone; 2000:2459-2474.
2. Von Graevenitz A. Ecology, clinical significance and antimicrobial susceptibility of infrequently encountered glucose-nonfermenting gram-negative rods. In: Gilardi GL, ed. Laboratory Identification and Clinical Aspects. New York: Marcel Dekker; 1985:181-232.
3. The Enterobacteriaceae. In: Koneman EW, Allen SD, Vanda WM, Schreckenberger PC, Winn WC, eds, Color Atlas and Textbook of Diagnostic Microbiology, 4th ed. Philadelphia: J, B. Lippincott; 1992:185-242.
4. Bloch KC, Nadarafah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Medicine 1997;76:30-41.
5. Schreckenberger PC, Graevenitz A. Non-fermentative gram-negative rods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 7th ed. Washington, DC: American Society for Microbiology; 1999:552-555.
6. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997. Approved standard M2-A6.
7. Amit Y, Peleg O, Singer R, Arad ID. Intravenous immunoglobulin for Flavobacterium-induced thrombocytopenia in a premature infant. Am J Perinatol 1991;8:161-163.
8. Gardner P, Griffin WB, Swartz MN, Kunz LJ. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med 1970;48:735-749.
9. Abrahamsen TG, Finne PH, Lingoas E, C. meningosepticum infections in a neonatal intensive care unit. Acta Pediatr Scand 1989;78:51-55.
10. Thong MC, Puthucheary SD, Lee E. C. meningosepticum infection: an epidemiological study in a newborn nursery. J Clin Pathol 1981;34:429-433.
11. Hogue SN, Graham J, Kaufmann ME, Tabagchali S. Chryseobacterium meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect 2001;47:188-192.
12. Hazuka BT, Dafoni AS, Talbot K, Keen BM. Two outbreaks of C. meningosepticum type E in a neonatal intensive care unit. J Clin Microbiol 1997;6:450-455.
13. Bruun B, Tversrupjensen E, Lundstrom K, Andersen GE. C. meningosepticum infection in a neonatal ward. Eur J Clin Microbiol Infect Dis 1989;816:509-514.
14. Dooley JR, Nims LJ, Lipp VH, Beard A, Delaney LT. Meningitis of infants caused by C. meningosepticum: report of a patient and analysis of 63 infections. J Trop Pediatr 1980;26:24-30.
15. Muder RR, Brennen C, Goetz AM, Wagener MM. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother 1991;35:256-258.
16. Horington SP, Perlino CA. C. meningosepticum sepsis: disease due to bacteria with unusual antibiotic susceptibility. South Med J 1981;74:764-766.
17. Johny M, Khufdash FA, Elhag KM. Antimicrobial treatment of C. meningosepticum infection. Ann Trop Paediatr 1983;3:125-128.
18. Di Pentima MC, Mason EO Jr, Kaplan SL. In vitro antibiotic synergy against Flavobacterium meningosepticum: implications for therapeutic options. Clin Infect Dis 1998;26:1169-1176.
19. Tizer KB, Cervia JS, Dunn AM, Stavola JJ, Noel GJ. Successful combination vancomycin and rifampin therapy in a newborn with community acquired C. meningosepticum neonatal meningitis. Pediatr Infect Dis J 1995;14:916-917.
20. Ratner H. C. meningosepticum. Infect Control 1984;5:237-239.
21. Lee EL, Robinson MJ, Thong ML, Puthucheary SD. Rifamycin in neonatal flavobacteria meningitis. Arch Dis Child 1976;51:209-213.